迈得医疗收盘下跌2.46%，最新市净率2.12，总市值17.80亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Maide Medical, indicating a significant decline in revenue and profit for the third quarter of 2024 [1] - As of September 30, 2024, Maide Medical has 4,462 shareholders, an increase of 520 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in the research, production, sales, and service of medical consumables and intelligent equipment, with key products in safety infusion and blood purification [1] Group 2 - The latest financial results show that Maide Medical achieved an operating income of 220 million yuan, a year-on-year decrease of 33.45%, and a net profit of 7.63 million yuan, down 89.37% year-on-year, with a gross profit margin of 48.86% [1] - The company's current price-to-earnings ratio (TTM) is -90.14, and the price-to-book ratio is 2.12, with a total market capitalization of 1.78 billion yuan [2] - Compared to industry averages, Maide Medical's financial metrics are significantly lower, with the industry average P/E ratio at 59.86 and average price-to-book ratio at 4.03 [2]